Cite
HARVARD Citation
Biesen, R. et al. (2022). Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy. Scandinavian journal of rheumatology. pp. 237-240. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Biesen, R. et al. (2022). Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy. Scandinavian journal of rheumatology. pp. 237-240. [Online].